Category North America

Letter Shows US Pressure On Global Fund For Compulsory Licensing, Generics

A 2011 letter from the top Republican on the United States Senate Finance Committee condemned efforts by the Global Fund to train public health officials on the use of flexibilities to the patent system contained in international trade rules. The letter, which also attacked the purchase of generic medicines over brand-name drugs, came just months before the US helped remove the head of the Global Fund, ultimately replacing him with an American official.

Year Ahead In IP, Biotech, Biodiversity: A Trio Fuelling Debates, Opportunities In 2013

The coming year promises to be very interesting at the intersection of intellectual property with biotechnology and biodiversity. Patentability of human genes in the United States, of conventionally bred plants in Europe, plant breeders' rights and the management of regulatory authorisations when patents on genetic traits expire, the future of genetically modified organisms in developing countries, and the usual resistance they are meeting from civil society and famers' groups are some of the issues that will continue to feed debates – and potentially create opportunities - in 2013.

Fate Of Google Book Search Still To Come, Expert Says

A few years ago, internet giant Google had the idea to digitise tens of millions of the world’s books and ran into legal trouble with the publishers and authors of some of them. The cases have moved through many stages, but the ultimate fate of the massive amounts of knowledge it could have made available to the public is still to come, says a Washington, DC lawyer who has followed the case closely for years.

Push For EU-US FTA Could Restart Discussions About IPRs

The high-level Munich Security Conference this weekend saw a considerable push for going forward with a Transatlantic Free Trade Agreement (TAFTA). Both US Vice-President Joe Biden and German Minister of Foreign Affairs Guido Westerwelle said such an agreement is within reach. But according to experts, negotiations also could re-open discussions on intellectual property protection.

Google Report Shows Steady Rise In Government Surveillance

US internet giant Google has released a report showing a steady climb in government surveillance online, which a tech industry group called "disturbing". The report, which covered from July through December of last year, includes more details than in the past, but does not include content takedowns, which now will be the subject of an upcoming separate report.

US FTC Finds Sharp Rise In ‘Pay-For-Delay’ Deals Blocking Generics

The United States Federal Trade Commission, which keeps an eye out for anticompetitive behaviour, has issued a study finding that in 2012, a record number of deals were struck between brand-name and generic drug companies to keep the lower-priced generics off the market. Such deals, which arise from patent disputes, cost American consumers billions of dollars annually while piling on the federal deficit, it said.